SLT Laser: A First-Line Alternative to Eye Drops
What Is SLT Laser Treatment for Glaucoma
Selective laser trabeculoplasty, commonly known as SLT, is a safe, in-office laser procedure that lowers eye pressure in patients with open-angle glaucoma or ocular hypertension. Traditionally, most newly diagnosed patients started treatment with daily eye drops, but landmark research now supports SLT as an equally effective or even superior first-line option. At Greenwich Ophthalmology Associates, our glaucoma specialists use SLT to help patients in the greater NY/CT region achieve lasting pressure control, often without the burden of daily medication. Understanding how this treatment works, what the procedure involves, and what results you can expect will help you make an informed decision about your glaucoma care.
SLT is a type of laser therapy designed to lower intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. It targets the trabecular meshwork, which is the eye's natural drainage tissue, to improve the outflow of fluid and reduce pressure.
During SLT, short pulses of low-energy laser light are applied to the pigmented cells in the trabecular meshwork. This stimulates a biological response that enhances the tissue's ability to drain aqueous humor, the clear fluid that fills the front of the eye. Because SLT uses selective photothermolysis, it treats only the pigmented target cells without causing thermal damage to surrounding structures. This mechanism sets SLT apart from older laser procedures and is a key reason the treatment can be safely repeated.
The trabecular meshwork is a sponge-like ring of tissue located where the iris meets the cornea, in an area called the drainage angle. In open-angle glaucoma, this tissue gradually becomes less efficient at draining fluid, causing pressure to build inside the eye. SLT restores some of that drainage capacity by triggering a cellular remodeling process within the meshwork. You can learn more about the full range of selective laser trabeculoplasty techniques we offer.
An earlier procedure called argon laser trabeculoplasty (ALT) used higher-energy laser pulses that created small burns on the trabecular meshwork. While ALT was effective, the scarring it produced limited the number of times it could be performed. SLT achieves comparable pressure reduction without causing structural damage, which means it can be repeated if needed. This advantage has made SLT the preferred laser trabeculoplasty approach in modern glaucoma care.
How the LiGHT Trial Supports SLT as First-Line Treatment
The Laser in Glaucoma and Ocular Hypertension (LiGHT) trial is the most significant clinical study to evaluate SLT as an initial treatment for glaucoma. Its findings have reshaped how glaucoma specialists around the world approach newly diagnosed patients.
The LiGHT trial was a large, multicenter, randomized controlled trial conducted across several sites in the United Kingdom. It enrolled patients with newly diagnosed open-angle glaucoma or ocular hypertension and randomly assigned them to receive either SLT or conventional eye drop therapy as their first treatment. Researchers then tracked both groups over several years, comparing pressure control, disease progression, quality of life, and the need for additional interventions.
At the three-year mark, 78% of eyes in the SLT group maintained their target pressure without needing any eye drops. The study also showed that patients who started with SLT required fewer glaucoma surgeries than those who began with medication. From a cost-effectiveness standpoint, SLT proved more economical because it eliminated the ongoing expense and adherence challenges associated with daily drops.
The six-year data confirmed and strengthened the earlier findings. Nearly 70% of eyes initially treated with SLT still achieved drop-free pressure control, and 90% of those successful eyes needed only one or two SLT sessions over the entire period. Importantly, eyes in the SLT group showed statistically lower rates of disease progression and a reduced need for both glaucoma surgery and cataract surgery compared to the eye drop group. A newer analysis of the LiGHT data presented at the American Academy of Ophthalmology found that SLT slowed visual field progression by 29% compared to daily drops.
What Happens During an SLT Procedure
SLT is performed as an outpatient procedure in the office. The entire process typically takes less than 30 minutes from start to finish, and most patients return to normal activities the same day.
Our glaucoma specialists will review your eye pressure readings, optic nerve health, and visual field results to confirm that SLT is appropriate for you. On the day of treatment, you will receive eye drops to constrict your pupil and numb the surface of your eye. These drops take about 15 to 20 minutes to take effect. You do not need to fast or arrange for sedation, though having someone available to drive you home is a good idea since your vision may be slightly blurry afterward.
You will sit at a slit lamp, the same type of microscope used during routine eye exams. A small contact lens is placed gently on your eye to help focus the laser beam onto the trabecular meshwork. The laser then delivers a series of brief, low-energy pulses to the drainage tissue. Most patients receive between 80 and 100 laser spots applied over a 180-degree or 360-degree arc. The treatment itself takes approximately five to ten minutes per eye, and most patients report feeling only mild, intermittent sensations during the process.
Your eye pressure will be checked about 30 to 60 minutes after treatment to ensure there is no initial pressure spike. You may experience mild redness, slight soreness, or a feeling of grittiness for a day or two, which typically resolves without intervention. Anti-inflammatory drops are usually prescribed for a few days following the procedure. A follow-up visit is scheduled within four to six weeks to assess your pressure response and determine whether additional treatment adjustments are needed. For a broader look at what healing looks like after different laser treatments, visit our page on glaucoma surgery recovery timelines.
How Effective Is SLT at Lowering Eye Pressure
SLT produces clinically meaningful pressure reductions in the majority of patients, though the degree of lowering varies based on individual factors.
On average, SLT lowers intraocular pressure by approximately 20% to 30% from baseline. For a patient with a starting pressure of 26 mmHg, that translates to a reduction of roughly five to eight points. Studies consistently show that success rates, defined as achieving at least a 20% reduction, range from 60% to 80% depending on the patient population and follow-up interval. The pressure-lowering effect generally becomes apparent within four to six weeks and reaches its full impact by about two to three months.
Patients with higher baseline pressures tend to experience a greater absolute reduction from SLT. The LiGHT trial data showed that among patients with baseline pressures of 25 mmHg or higher, SLT outperformed drops, with nearly 98% of those at 30 mmHg or above achieving at least a 20% reduction. Other factors that can influence results include the degree of trabecular meshwork pigmentation, the type of glaucoma, and whether the patient has had prior laser treatments.
SLT is most commonly used for primary open-angle glaucoma and ocular hypertension, but it can also benefit patients with pseudoexfoliative glaucoma and pigmentary glaucoma. It is not effective for angle-closure glaucoma because the drainage angle must be open for the laser to reach the trabecular meshwork. If you are unsure whether your type of glaucoma is suitable for SLT, our team can discuss the full range of glaucoma laser surgery options available to you.
Frequently Asked Questions
The pressure-lowering effect of SLT typically lasts between two and five years, with some patients maintaining good control even longer. Over time, the biological response in the trabecular meshwork gradually diminishes, and your pressure may begin to rise again. Regular monitoring allows our glaucoma specialists to detect any changes early so that treatment can be adjusted before vision is affected.
Yes, one of the most significant advantages of SLT over older laser procedures is that it can be safely repeated. Because SLT does not cause permanent structural damage to the trabecular meshwork, a second or even third treatment can be performed when the initial effect fades. Research shows that repeat SLT achieves a similar degree of pressure reduction as the first session, and in the LiGHT trial, the repeat treatment demonstrated a longer duration of effect than the initial session. In the six-year data, 90% of patients who remained drop-free had needed only one or two SLT treatments total.
SLT has a very favorable safety profile. The most common side effects include temporary eye redness, mild inflammation, and a transient increase in eye pressure within the first few hours after treatment. These effects are typically mild and resolve within a few days with anti-inflammatory eye drops. Serious complications are rare, and SLT does not carry the systemic side effects that can accompany daily glaucoma medications, such as fatigue, breathing difficulties, or changes in heart rate associated with beta-blocker drops.
Both SLT and eye drops are effective at lowering intraocular pressure, but they differ significantly in terms of convenience and long-term outcomes. Eye drops require consistent daily use, often one to three times per day, and adherence can be challenging. Many patients forget doses, experience irritating side effects, or struggle with the physical act of instilling drops. SLT eliminates these daily compliance concerns with a single in-office treatment. The LiGHT trial confirmed that SLT achieves comparable or better pressure control, with reduced disease progression and fewer surgical interventions over six years. To explore the broader question of when more advanced intervention may be needed, see our page on when glaucoma surgery is needed.
SLT is covered by most major medical insurance plans, including Medicare, because it is classified as a medically necessary procedure for glaucoma and ocular hypertension. Out-of-pocket costs will depend on your specific plan, deductible, and copay structure. Many patients find that SLT is more cost-effective over time than the cumulative expense of brand-name glaucoma drops, which can cost hundreds of dollars per month without insurance. Our team can help verify your coverage before scheduling the procedure.
SLT is appropriate for a wide range of patients. It is an excellent option for those newly diagnosed with open-angle glaucoma or ocular hypertension who want to avoid or delay the start of daily eye drops. It is also well-suited for patients already on drops who want to reduce their medication burden, those who experience side effects from glaucoma medications, or patients who have difficulty with drop adherence. SLT may be less effective in eyes that have had extensive prior laser treatment to the trabecular meshwork or in certain secondary glaucomas. For patients who may benefit from other laser approaches, our practice also offers laser peripheral iridoplasty for specific angle-related conditions.
Schedule Your SLT Consultation
If you have been diagnosed with glaucoma or ocular hypertension and want to explore a proven alternative to daily eye drops, our fellowship-trained glaucoma specialists at Greenwich Ophthalmology Associates are here to help. We will evaluate your individual condition, review your treatment history, and determine whether SLT is the right next step for your eye health. Our goal is to help you achieve lasting pressure control with the approach that fits your needs and your lifestyle.
We encourage you to bring your questions and concerns to your next appointment so we can develop a care plan that addresses your goals and lifestyle.
Learn More About Related Topics
To further your understanding, explore our resources on Brimonidine Eye Drops for Glaucoma, Glaucoma Eye Drops: Complete Medication Guide, and Glaucoma Eye Drops: Side Effects and How to Manage Them.
You may also find these pages helpful: Glaucoma Treatment Options: Drops, Laser and Surgery, Caffeine and Eye Pressure: What Research Shows, and Does Caffeine Increase Eye Pressure?.
What our Patients say
4.8
Reviews
(3645)